These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23682923)

  • 41. β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.
    Sinnollareddy MG; Roberts MS; Lipman J; Roberts JA
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):489-96. PubMed ID: 22519600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumonia.
    Ranzani OT; Ferrer M; Esperatti M; Giunta V; Bassi GL; Carvalho CR; Torres A
    Crit Care Med; 2012 Sep; 40(9):2552-61. PubMed ID: 22732293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimizing pediatric dosing: a developmental pharmacologic approach.
    Anderson GD; Lynn AM
    Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How to measure pharmacokinetics in critically ill patients?
    Liu X; Kruger PS; Roberts MS
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2037-43. PubMed ID: 21554213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and Pharmacodynamics of Antimicrobials in Critically Ill Patients.
    Owen EJ; Gibson GA; Buckman SA
    Surg Infect (Larchmt); 2018; 19(2):155-162. PubMed ID: 29272204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measuring drug distribution in the critically ill patient.
    Deitchman AN; Derendorf H
    Adv Drug Deliv Rev; 2014 Nov; 77():22-6. PubMed ID: 25194997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics, Metabolism, Distribution and Permeability of Nanomedicine.
    Ravindran S; Suthar JK; Rokade R; Deshpande P; Singh P; Pratinidhi A; Khambadkhar R; Utekar S
    Curr Drug Metab; 2018; 19(4):327-334. PubMed ID: 29512450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling for critically ill patients: An introduction for beginners.
    Lafont E; Urien S; Salem JE; Heming N; Faisy C
    J Crit Care; 2015 Dec; 30(6):1287-94. PubMed ID: 26719063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors.
    Yousuf M
    Curr Cancer Drug Targets; 2019; 19(11):906-918. PubMed ID: 30894110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic and pharmacodynamic alterations in older people with dementia.
    Reeve E; Trenaman SC; Rockwood K; Hilmer SN
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):651-668. PubMed ID: 28460576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery.
    Lucas AJ; Sproston JL; Barton P; Riley RJ
    Expert Opin Drug Discov; 2019 Dec; 14(12):1313-1327. PubMed ID: 31538500
    [No Abstract]   [Full Text] [Related]  

  • 52. The impact of sepsis on hepatic drug metabolism in critically ill patients: a narrative review.
    Ewoldt TM; Abdulla A; Hunfeld N; Li L; Smeets TJL; Gommers D; Koch BCP; Endeman H
    Expert Opin Drug Metab Toxicol; 2022 Jun; 18(6):413-421. PubMed ID: 35912845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of critical illness on drug distribution.
    Gonzalez D; Conrado DJ; Theuretzbacher U; Derendorf H
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2030-6. PubMed ID: 21554214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alterations in drug disposition in older adults.
    Reeve E; Wiese MD; Mangoni AA
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):491-508. PubMed ID: 25600059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioavailability of Orally Administered Drugs in Critically Ill Patients.
    Forsberg J; Bedard E; Mahmoud SH
    J Pharm Pract; 2023 Aug; 36(4):967-979. PubMed ID: 35521821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and pharmacodynamics in the critically ill patient.
    Park GR
    Xenobiotica; 1993 Nov; 23(11):1195-230. PubMed ID: 8310706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hormone-related pharmacokinetic variations associated with anti-breast cancer drugs.
    Li J; Ma Z; Jiang RW; Wu B
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1085-95. PubMed ID: 23687971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Age-mediated changes in the gastrointestinal tract.
    Merchant HA; Liu F; Orlu Gul M; Basit AW
    Int J Pharm; 2016 Oct; 512(2):382-395. PubMed ID: 27085646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medicine management: pharmacokinetic update for community nurses.
    Khan E
    Br J Community Nurs; 2010 Sep; 15(9):436-44. PubMed ID: 20852525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic behavior presents drug therapy challenges.
    Slaughter RL
    Expert Rev Clin Pharmacol; 2013 Nov; 6(6):627-39. PubMed ID: 24164611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.